| Primary |
| Postoperative Care |
37.1% |
| Conjunctivitis |
16.2% |
| Ear Infection |
6.7% |
| Eye Operation |
4.8% |
| Eye Infection |
3.8% |
| Tonsillar Disorder |
3.8% |
| Uveitis |
3.8% |
| Blepharitis |
2.9% |
| Cataract Operation |
2.9% |
| Anaesthesia |
1.9% |
| Chalazion |
1.9% |
| Eye Injury |
1.9% |
| Inflammation |
1.9% |
| Intraocular Pressure Increased |
1.9% |
| Keratitis |
1.9% |
| Promotion Of Wound Healing |
1.9% |
| Rhinitis |
1.9% |
| Abscess |
1.0% |
| Corneal Abrasion |
1.0% |
| Corneal Oedema |
1.0% |
|
| Vitritis |
18.6% |
| Vision Blurred |
10.0% |
| Ocular Hyperaemia |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Lipogranuloma |
5.7% |
| Off Label Use |
5.7% |
| Hypoacusis |
4.3% |
| Intraocular Pressure Increased |
4.3% |
| Ulcerative Keratitis |
4.3% |
| Uveitis |
4.3% |
| Deafness |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Dysgeusia |
2.9% |
| Encephalopathy |
2.9% |
| Hypersensitivity |
2.9% |
| Increased Insulin Requirement |
2.9% |
| Keratitis |
2.9% |
| Optic Nerve Disorder |
2.9% |
| Pruritus |
2.9% |
| Thrombocytopenia |
2.9% |
|
| Secondary |
| Cataract Operation |
29.4% |
| Eye Operation |
14.7% |
| Postoperative Care |
10.6% |
| Eye Inflammation |
9.2% |
| Corneal Erosion |
6.9% |
| Product Used For Unknown Indication |
5.5% |
| Anaesthesia |
3.7% |
| Prophylaxis |
3.2% |
| Drug Use For Unknown Indication |
2.8% |
| Keratitis |
2.8% |
| Photorefractive Keratectomy |
2.3% |
| Ear Infection |
1.4% |
| Local Anaesthesia |
1.4% |
| Arrhythmia |
0.9% |
| Cardiac Disorder |
0.9% |
| Cardiac Failure |
0.9% |
| Cataract |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Conjunctivitis |
0.9% |
| Ear Pain |
0.9% |
|
| Hypersensitivity |
17.5% |
| Inflammation |
12.3% |
| Vitritis |
10.5% |
| Ulcerative Keratitis |
7.0% |
| Uveitis |
7.0% |
| Vision Blurred |
7.0% |
| Conjunctivitis |
3.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.5% |
| Fluid Retention |
3.5% |
| No Therapeutic Response |
3.5% |
| Off Label Use |
3.5% |
| Organ Transplant |
3.5% |
| Retinal Haemorrhage |
3.5% |
| Urticaria |
3.5% |
| Adverse Event |
1.8% |
| Cataract Operation |
1.8% |
| Cellulitis Orbital |
1.8% |
| Choroidal Infarction |
1.8% |
| Conjunctival Hyperaemia |
1.8% |
| Convulsion |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.7% |
| Drug Use For Unknown Indication |
12.9% |
| Hypertension |
6.0% |
| Back Pain |
5.4% |
| Pain |
5.0% |
| Osteoporosis |
4.7% |
| Infection |
4.6% |
| Breast Cancer |
4.3% |
| Hormone Replacement Therapy |
3.7% |
| Depression |
3.4% |
| Renal Transplant |
2.9% |
| Diabetes Mellitus |
2.8% |
| Restless Legs Syndrome |
2.8% |
| Postoperative Care |
2.7% |
| Metastases To Bone |
2.5% |
| Anxiety |
2.4% |
| Contraception |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Osteoarthritis |
2.3% |
| Prophylaxis |
2.2% |
|
| Weight Decreased |
8.8% |
| Urinary Tract Infection |
8.1% |
| Vomiting |
7.4% |
| Pneumonia |
5.4% |
| Tachypnoea |
5.4% |
| Tremor |
5.4% |
| Weight Increased |
5.4% |
| Multi-organ Failure |
4.7% |
| Road Traffic Accident |
4.7% |
| Umbilical Hernia |
4.7% |
| Vision Blurred |
4.7% |
| Pain |
4.1% |
| Pulmonary Embolism |
4.1% |
| Rectal Haemorrhage |
4.1% |
| Ventricular Extrasystoles |
4.1% |
| Viral Infection |
4.1% |
| Vitreous Haemorrhage |
4.1% |
| X-ray Abnormal |
4.1% |
| Renal Failure |
3.4% |
| Skin Tightness |
3.4% |
|
